Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Ken Moorhouse
Ken Moorhouse manages Patient Prospect, a done-for-you service offering social media solutions focused on helping practitioners who want to build their online presence and reach new prospects in their community. Patient Prospect creates, manages and publishes all your social media content for your practice so you can spend more time helping patients. To learn more, please visit https://PatientProspect.com.